Arun Singh, MD, and colleagues developed a model that provides direct diagnostic prediction of a lesion being iris melanoma. He is Director of the Department of Ophthalmic Oncology, Cole Eye Institute at the Cleveland Clinic, Cleveland Clinic Main Campus Hospital, Cleveland.
Of Interest
Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma
Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.
Global research team develops diagnostic model for iris melanoma
Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model
Radioactive iodine for thyroid cancer linked to risk for melanoma, other skin cancers
Patients with primary thyroid cancer who received radioactive iodine therapy had elevated risk for melanoma/skin cancer.